Alopecia areata after SARS-CoV-2 vaccination
Margaret E. Scollan, Alyssa Breneman, Neha Kinariwalla, Yssra Soliman, Soundos Youssef, Lindsey A. Bordone, Stephanie M. Gallitano
Abstract
Alopecia areata (AA) is a T lymphocyte-mediated autoimmune condition characterized by hair loss due to an inflammatory response targeting the hair follicle. Recent reports have suggested that COVID-19 may trigger a variety of autoimmune conditions, including AA.1,2 Herein, we report 9 cases of AA following SARS-CoV-2 vaccination (Table I; Fig 1).
Topics & Concepts
Alopecia areataMedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyImmunologyHair follicleVaccination2019-20 coronavirus outbreakHair lossVirologyPathologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakHair Growth and DisordersAutoimmune Bullous Skin DiseasesAutoimmune and Inflammatory Disorders